Sony’s Tom Rothman Gives Tough Love to Theaters at CinemaCon

Sony used its CinemaCon showcase to highlight a 2026 film slate anchored by Spider-Man and Jumanji, while Tom Rothman urged theaters to cut pre-film ads, lower prices, and support longer theatrical windows to help reverse pre-COVID attendance declines. The studio said 2025 domestic grosses were only $560 million, but it also pointed to a major bright spot in 'Demon Slayer: Infinity Castle,' which grossed $738.5 million worldwide and became the highest-grossing anime film ever. Overall, the piece is more strategic and promotional than financially material, with modest implications for theater economics and Sony’s upcoming release cycle.

Analysis

The key takeaway is not the studio slate; it’s Rothman implicitly admitting exhibition is still the bottleneck for attendance recovery. If theaters can reduce friction and price elasticity pain, the demand upside accrues first to the studios with the deepest franchise flywheel, because they capture incremental box office without needing proportional marketing spend. SONY’s 2026 mix is especially levered to that outcome: a stronger theater recovery improves not just domestic grosses but also the economics of windowing and downstream licensing, which are more important than the headline release list.

The second-order winner is premium IP distribution, while the loser is the middle of the market. If theaters get serious about shorter ad pods and lower effective ticket prices, they will likely optimize for tentpoles and eventized titles, squeezing smaller films that rely on casual walk-up traffic. That favors studios with recognizable brands and global sequel cadence; it also argues that the real competitive risk to SONY is not Disney or Warner on a single title, but an industry-wide shift where exhibitors become more selective and barbell their screens toward a smaller set of bankable films.

Contrarianly, the market may be underestimating how much of SONY’s upside is already embedded in expectations for 2026 franchise performance. The near-term catalyst is not the speech itself but whether exhibitor behavior changes over the next 1-2 quarters; if it does not, the box-office thesis fades quickly and the market will re-rate any 2026 optimism back into “wait and see.” The strongest asymmetry is on the downside if one of the marquee releases underperforms: SONY has less diversification than the largest studios, so a single franchise miss can dominate sentiment for months.

On the positive side, animation and anime remain a structural offset: the company’s biggest recent breakout shows there is still room for nontraditional content to travel globally when audience passion is high. That matters because it lowers dependence on the domestic theater recovery and gives SONY an additional monetization channel if theatrical traffic remains choppy.

Key Decisions for Investors

• Long SONY into the next 6-12 months only on pullbacks; the setup is asymmetric if 2026 franchise titles convert exhibitor cooperation into higher per-screen attendance, but stop out if theater-traffic indicators do not improve by mid-year.
• Pair trade: long SONY / short a broader media basket with less franchise concentration over 3-6 months; SONY should outperform if box office broadens, but the trade breaks if exhibitors continue prioritizing only top-decile tentpoles.
• Buy SONY Jan-2027 calls or call spreads to express the 2026 slate optionality with defined downside; this is cleaner than equity because the catalyst is time-dependent and could take several quarters to surface.
• Avoid chasing theater-equity beta on the headline; the memo is actually bearish for mid-tier exhibition and small-event films, so any long on cinema operators should require proof of pricing power and lower ad clutter within 1-2 quarters.
• Watch for a downgrade trigger if the first major 2026 Sony tentpole weakens in pre-sales; that would likely compress multiple expansion quickly and justify reducing SONY exposure before the broader market reprices the slate.